Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-26

Clinical Trial Update: Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes [NA]

View source ↗

Summary

The study evaluated nicotine pharmacokinetics after using the P4M3 Gen 2.0 e-cigarette compared with traditional cigarette smoking, with results posted on 2024-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotine (nicotine)

Snippet

Sponsor: Philip Morris Products S.A. | Conditions: Nicotine Vaping, Nicotine | NA | Status: COMPLETED | Results posted: 2024-04-26